Skip to main content
. 2022 Feb 7;63(2):15. doi: 10.1167/iovs.63.2.15

Figure 1.

Figure 1.

Effect of CKLP1 on TGFβ2 ocular hypertensive mice. Once daily treatment with 5 mM CKLP1 significantly lowered IOP in TGFβ2 overexpressing mice by 20% (n = 6; P < 0.0001) when compared with the vehicle treated contralateral eye. IOP returned to baseline within 72 hours of cessation of treatment (n = 6; P = 0.1). Pretreatment refers to IOP measured before treating with CKLP1, but after injection of Ad.TGFβ2226/228 or control in the mice eyes.